COMMUNIQUÉS West-GlobeNewswire

Vaso Corporation Announces Financial Results for First Quarter of 2025
15/05/2025
PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales [...]
Intuitive Announces CEO Transition Effective July 1, 2025
15/05/2025
President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive’s board Current Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE [...]
NewsWatchTV Ranks Riti as the Best Testosterone Booster, Right Behind TestoPrime and TestoGen
15/05/2025
News Watch TV ranks Riti’s T-Booster third among top testosterone supplements, highlighting formulation, quality, and user feedback in their 2025 review. Dover, Delaware, May 15, 2025 (GLOBE NEWSWIRE) -- Riti, a [...]
Silo Pharma Announces Pricing of $2 Million Public Offering
15/05/2025
SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
SRx Health Solutions Further Diversifies Treasury Strategy with Purchase of Bitcoin; Company to Form a Crypto Treasury Subsidiary with Plan to Partner with an Industry Leader
15/05/2025
TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced further diversifying its treasury strategy [...]
CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
15/05/2025
In a release issued under the same headline earlier today by Mersana Therapeutics, Inc. (NASDAQ: MRSN), please note that there was a transcription error in the last cell of the first table. The Median OS should have [...]
New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Practice
15/05/2025
Arcutis convened the Genital Psoriasis Wellness Consortium, a multidisciplinary group of clinicians who are experts in their fields Publication includes 14 consensus statements aimed at improving diagnosis, treatment, [...]
Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
15/05/2025
CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
15/05/2025
BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
Summit Products Group Launches to Transform Surgical and Regenerative Healthcare
15/05/2025
Announces Strategic Alliance with Medtech Pioneer NovaBone DALLAS, May 15, 2025 (GLOBE NEWSWIRE) -- Providers now have access to new surgical options designed to support precision and regeneration in the operating room [...]
Elucent Medical Receives FDA Breakthrough Device Designation for EnVisio X1™ In-Body Spatial Intelligence™ System
15/05/2025
Next-generation localization platform marks paradigm shift in minimally invasive surgery, elevating precision in cancer care MINNEAPOLIS, May 15, 2025 (GLOBE NEWSWIRE) -- Elucent Medical (“Elucent”), a leading innovator [...]
Klothea Bio Collaborates with Healthy Longevity Clinic, a Top 40 Semifinalist in $101 million XPRIZE Healthspan Competition
15/05/2025
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Klothea Bio Inc. , a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing collaboration with Healthy [...]
IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling Initiative
15/05/2025
Leading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping Project Based on UK Patient Big Data SEOUL, South Korea, May 15, 2025 (GLOBE NEWSWIRE) -- Curiox Biosystems [...]
Beacon Behavioral Partners Accelerates Mission to Expand Mental Health Access Nationwide With Addition of Five New Partners
15/05/2025
Network Continues Closing Critical Gaps in Behavioral Healthcare and Building the Infrastructure to Support Providers BATON ROUGE, La., May 15, 2025 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP) , one of the [...]
ABM Respiratory Care and Delve Health Launch Home Care Study to Evaluate BiWaze® Clear System in Patients with Bronchiectasis
15/05/2025
EAGAN, Minn., May 15, 2025 (GLOBE NEWSWIRE) -- ABM Respiratory Care, an innovator in respiratory therapy solutions, announced today the initiation of a multi-center home care study in collaboration with Delve Health, a [...]
Dr. Jose Arnold Tariga from the USA Selected as Finalist for Aster Guardians Global Nursing Award 2025 Worth USD 250,000
15/05/2025
Dr. Jose Arnold Tariga, a distinguished Filipino-American nursing educator and workforce equity advocate based in Boston, USA, has been selected as one of the top 10 finalists for the Aster Guardians Global Nursing [...]
Moana Beauty Spa Announces Advanced LED Facelift Protocol, Attracting International Clients to Waikiki for Non-Surgical Rejuvenation
15/05/2025
Honolulu, Hawaii , May 15, 2025 (GLOBE NEWSWIRE) -- Moana Beauty Spa , a leading destination for non-invasive skincare in Waikiki, today announced the expansion of its advanced LED facelift protocol, a revolutionary non [...]
vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes
15/05/2025
Topline CATT1 Phase 3 data is expected in 2H 2026 Protocol amendment shortens trial duration from 12 to 6 months, expediting time to topline data HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc [...]
Polpharma Group plaide en faveur d’une action urgente en vue de garantir aux patients européens un accès équitable et précoce aux médicaments
15/05/2025
Polpharma Group participe à l’appel à l’action visant la finalisation de la réforme de la législation pharmaceutique et la garantie d’un accès durable et précoce aux soins de santé pour les patients européens VARSOVIE, [...]

Pages